Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Panacea Pharmaceuticals, Inc. Announces Agreements with Case Western Reserve University for Alzheimer's Disease Specific Oxidative Stress Model
- Business Editors/Health & Medical Writers
- Research articles 2000-07-10
- UNIVERSITY OF OXFORD, AMERSHAM HEALTHCARE, AND BRISTOL-MYERS SQUIBB SIGN AGREEMENT INVOLVING TEST FOR ALZHEIMER'S DISEASE; New imaging technique could speed detection, help evaluate new treatments, and receive expedited review at FDA
- ARLINGTON HEIGHTS, Ill.--HealthWire--March 29, 1996-- Medi-Physics Inc., Amersham Healthcare announced today a licensing agreement between its UK-based parent, Amersham International plc, Bristol-Myers Squibb Company (NYSE: BMY), and the University of Oxford, one of Britain's premier universities and medical centers. The agreement will likely result in Medi-Physics petitioning the U.S. Food...
- Research articles 1996-03-29
- AXONYX Enters Into a Collaborative Development Agreement With the University of Melbourne to Develop a Diagnostic Test for Alzheimer's Disease
- NEW YORK--BUSINESS WIRE--Oct. 4, 1999--
- Research articles 1999-10-04
- Applied NeuroSolutions Announces Agreement with Eli Lilly and Company to Develop Therapeutics to Treat Alzheimer's Disease
- Applied NeuroSolutions Receives Cash and Equity Investment; Establishes Collaboration for Novel Approach Toward Alzheimer's Disease Treatments
- Research articles 2006-11-28
- Nymox announces new agreement for Alzheimer's Disease Therapeutics With Massachusetts General Hospital
- MONTREAL--BUSINESS WIRE--March 11, 1997--NYMOX PHARMACEUTICAL (ME: NMX) -- The Massachusetts General Hospital MGH and Nymox Pharmaceutical Corporation have signed a new research and licensing agreement to develop therapeutic applications of technology associated with the Neuronal Thread Protein NTP gene.
- Research articles 1997-03-11
- << Previous
- page 1 of 1
- Next >>
